Renalytix Plc (AIM:RENX)
London · Delayed Price · Currency is GBP · Price in GBX 2.800
+0.150 (5.66%)
Jul 28, 2026, 8:18 AM GMT
Renalytix Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 3.3 | 3 | 2.3 | 3.4 | 2.97 | 1.49 | |
Revenue Growth | 38.48% | 30.44% | -32.41% | 14.58% | 99.19% | - |
Cost of Revenue | -1.8 | -1.8 | -2.1 | -2.7 | -2.05 | -0.8 |
Gross Profit | 1.5 | 1.2 | 0.2 | 0.7 | 0.92 | 0.69 |
Selling, General & Admin | -18.3 | -18.4 | -30.7 | -43.06 | -58.29 | -33.3 |
Other Operating Expenses | - | 0 | 10.5 | - | - | - |
Total Operating Expenses | -18.3 | -18.4 | -20.2 | -43.06 | -58.29 | -33.3 |
Operating Income | -16.8 | -17.2 | -30.5 | -42.36 | -57.37 | -32.61 |
Total Non-Operating Income (Expense) | -4.5 | -4.6 | -4.5 | -3.87 | 7.74 | -3.18 |
Pretax Income | -21.3 | -21.8 | -45.5 | -46.22 | -49.63 | -35.79 |
Provision for Income Taxes | 1.4 | 1.4 | - | -0 | -7.1 | 4.78 |
Net Income | -19.9 | -20.4 | -45.5 | -46.22 | -56.73 | -31.01 |
Net Income to Common | -19.9 | -20.4 | -45.5 | -46.22 | -56.73 | -31.01 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 386 | 275 | 108 | 82 | 73 | 71 |
Shares Outstanding (Diluted) | 386 | 275 | 108 | 82 | 74 | 71 |
Shares Change | 178.31% | 153.82% | 31.59% | 11.34% | 3.29% | 21.00% |
EPS (Basic) | -0.04 | -0.07 | -0.42 | -0.56 | -0.78 | -0.43 |
EPS (Diluted) | -0.04 | -0.07 | -0.42 | -0.56 | -0.82 | -0.43 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | 10.31 | -0.02 | -29.8 | -32.67 | -46.34 | -25.42 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | 0.03 | -0.00 | -0.28 | -0.40 | -0.63 | -0.36 |
Gross Margin | 45.45% | 40.00% | 8.70% | 20.60% | 30.91% | 46.08% |
Operating Margin | -509.09% | -573.33% | -1326.09% | -1244.64% | -1931.72% | -2187.19% |
Profit Margin | -603.03% | -680.00% | -1978.26% | -1358.30% | -1910.17% | -2079.81% |
FCF Margin | 312.31% | -0.60% | -1295.65% | -960.15% | -1560.13% | -1704.56% |
EBITDA | -16.83 | -17.2 | -28 | -39.86 | -54.76 | -30.52 |
EBITDA Margin | -509.88% | -573.33% | -1217.39% | -1171.41% | -1843.74% | -2046.61% |
EBIT | -16.8 | -17.2 | -30.5 | -42.36 | -57.37 | -32.61 |
EBIT Margin | -509.09% | -573.33% | -1326.09% | -1244.64% | -1931.72% | -2187.19% |
Effective Tax Rate | -6.57% | -6.42% | 0.00% | 0.00% | 14.31% | -13.35% |